Overview of PGxHealth
PGxHealth, a division of Clinical Data, Inc., is leveraging its biomarker discovery expertise and intellectual property to develop and commercialize targeted therapeutics, as well as genetic and pharmacogenomic tests to detect serious diseases and help predict drug safety, tolerability and efficacy. PGxHealth has built the commercial, managed care and CLIA-certified laboratory infrastructure and capabilities to support our currently marketed tests including the FAMILION® family of genetic tests for inherited heart diseases and PGxPredict™ tests for predicting drug response.